
UK-US Drug Deal Could Redirect £45bn from NHS Care, Warns Doctors’ Union
The National Health Service (NHS) faces a critical funding crisis as a new pharmaceutical agreement between the UK and the US threatens to siphon off approximately £45 billion from vital healthcare services. This shift, highlighted by a recent analysis from a leading doctors’ union, could result in an alarming increase of 229,000 potentially preventable deaths across the UK.

















